411 related articles for article (PubMed ID: 27744604)
1. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
[TBL] [Abstract][Full Text] [Related]
2. Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
Kelley WL; Jousselin A; Barras C; Lelong E; Renzoni A
Antimicrob Agents Chemother; 2015 Apr; 59(4):1922-30. PubMed ID: 25583724
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
Alm RA; McLaughlin RE; Kos VN; Sader HS; Iaconis JP; Lahiri SD
J Antimicrob Chemother; 2014 Aug; 69(8):2065-75. PubMed ID: 24777906
[TBL] [Abstract][Full Text] [Related]
5. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
[TBL] [Abstract][Full Text] [Related]
7. Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
Schaumburg F; Peters G; Alabi A; Becker K; Idelevich EA
J Antimicrob Chemother; 2016 Jan; 71(1):41-4. PubMed ID: 26443816
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
[TBL] [Abstract][Full Text] [Related]
9. Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus.
Lee H; Yoon EJ; Kim D; Kim JW; Lee KJ; Kim HS; Kim YR; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Jeong SH
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941637
[TBL] [Abstract][Full Text] [Related]
10. Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
Lahiri SD; Alm RA
J Antimicrob Chemother; 2016 Jan; 71(1):34-40. PubMed ID: 26483514
[TBL] [Abstract][Full Text] [Related]
11. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
Zhang H; Xiao M; Kong F; O'Sullivan MV; Mao LL; Zhao HR; Zhao Y; Wang H; Xu YC
Int J Antimicrob Agents; 2015 Apr; 45(4):347-50. PubMed ID: 25649348
[TBL] [Abstract][Full Text] [Related]
12. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
Urbán E; Stone GG
Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular epidemiology of ceftaroline non-susceptible methicillin-resistant Staphylococcus aureus isolates, first clinical report from Iran.
Khoshbayan A; Shariati A; Ghaznavi-Rad E; van Belkum A; Darban-Sarokhalil D
Acta Microbiol Immunol Hung; 2020 Dec; 67(4):228-233. PubMed ID: 33258796
[TBL] [Abstract][Full Text] [Related]
14. PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.
Long SW; Olsen RJ; Mehta SC; Palzkill T; Cernoch PL; Perez KK; Musick WL; Rosato AE; Musser JM
Antimicrob Agents Chemother; 2014 Nov; 58(11):6668-74. PubMed ID: 25155594
[TBL] [Abstract][Full Text] [Related]
15. High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant
Morroni G; Brenciani A; Brescini L; Fioriti S; Simoni S; Pocognoli A; Mingoia M; Giovanetti E; Barchiesi F; Giacometti A; Cirioni O
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275082
[TBL] [Abstract][Full Text] [Related]
16.
Gaikwad V; Gohel T; Panickar S; Chincholkar V; Mangalkar S
Indian J Pathol Microbiol; 2016; 59(4):496-498. PubMed ID: 27721280
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotypic relatedness of methicillin resistant Staphylococcus aureus in a tertiary care hospital.
Fomda BA; Thokar MA; Bashir G; Khan A; Kour A; Zahoor D; Ray P
J Postgrad Med; 2014; 60(4):386-9. PubMed ID: 25370547
[TBL] [Abstract][Full Text] [Related]
18. Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance.
Bongiorno D; Mongelli G; Stefani S; Campanile F
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114852. PubMed ID: 31288948
[TBL] [Abstract][Full Text] [Related]
19. PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK.
Harrison EM; Ba X; Blane B; Ellington MJ; Loeffler A; Hill RL; Holmes MA; Peacock SJ
J Antimicrob Chemother; 2016 Jan; 71(1):268-9. PubMed ID: 26462986
[No Abstract] [Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014.
Fang H; Fröding I; Gian B; Hæggman S; Tollström UB; Ullberg M; Nord CE
J Glob Antimicrob Resist; 2016 Jun; 5():31-5. PubMed ID: 27436463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
